Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Propolis, a resinous substance produced by bees, has been traditionally used for its antimicrobial and anti-inflammatory properties. In the context of conjunctivitis (inflammation of the eye's conjunctiva), there is emerging scientific interest in its potential benefits. Laboratory studies have demonstrated that propolis exhibits significant antibacterial, antiviral, and anti-inflammatory effects, which are theoretically relevant for treating conjunctivitis, especially of infectious origin. A limited number of animal studies and in vitro experiments suggest that propolis extracts can inhibit the growth of common conjunctivitis-causing pathogens and reduce inflammatory responses in ocular tissues.

However, clinical evidence in humans is minimal. Only a few small-scale studies and anecdotal reports have evaluated the effectiveness of propolis in treating conjunctivitis, and these often lack rigorous controls or sufficient sample sizes. Furthermore, the safety of topical ocular application of propolis in humans has not been thoroughly established, with the potential for allergic reactions being a concern.

In summary, while there is a plausible scientific rationale and some preliminary laboratory support for the use of propolis in conjunctivitis, the evidence base is currently weak (rated 2/5). Robust, well-designed clinical trials are required before propolis can be recommended as a mainstream or adjunctive treatment for conjunctivitis.

More about Propolis
More about Conjunctivitis

Other ingredients used for Conjunctivitis

Other health conditions supported by Propolis

Products containing Propolis